New study pits heat, cold, and knife against lung cancer

NCT ID NCT07272356

Ongoing Disease control Sponsor: Aurimas Macionis Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study compares three standard treatments for lung tumors: surgery, targeted radiation (SBRT), and minimally invasive thermal ablation (using heat or cold to destroy tumors). About 68 adults with early-stage lung cancer or limited lung metastases will be followed for two years. Researchers will measure how well each treatment controls cancer, affects breathing, and impacts quality of life, aiming to guide personalized treatment decisions.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Thermal ablation (microwave or cryoablation)
What this could lead to: If successful, this could help doctors choose the best treatment for each patient, balancing cancer control with preserving lung function and quality of life.
What could go wrong: This is a small, non-randomized study with only 68 participants, so results may not apply to everyone. The treatments are already standard, so no major breakthrough is expected.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for LUNG CANCER (NON-SMALL CELL) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

non-small cell lung carcinoma Respiratory Aspiration

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

LUNG CANCER (NON-SMALL CELL) LUNG METASTASES FROM ANY PRIMARY

Contacts and locations

Locations

Lithuanian University of Health Sciences Kaunas Clinics

Kaunas, 50161, Lithuania

More trials for these conditions

Other studies related to the condition(s) this trial covers.